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ABSTRACT 
Five species of parasite cause malaria in humans with the most severe disease caused by 
Plasmodium falciparum. Many of the proteins encoded in the P. falciparum genome are 
unusually enriched in repetitive low complexity sequences containing a limited repertoire of 
amino acids.  These repetitive sequences expand and contract dynamically and are among the 
most rapidly changing sequences in the genome. The simplest repetitive sequences consist of 
single amino acid repeats such as poly-asparagine tracts which are found in approximately 
25% of P. falciparum proteins. More complex repeats of two or more amino acids are also 
common in diverse parasite protein families. There is no universal explanation for the 
occurrence of repetitive sequences and it is possible that many confer no function to the 
encoded protein and no selective advantage or disadvantage to the parasite. However, there 
are increasing numbers of examples where repetitive sequences are important for parasite 
protein function. We discuss the diverse roles of low complexity repetitive sequences 
throughout the parasite life cycle, from mediating protein-protein interactions to enabling the 
parasite to evade the host immune system. 
INTRODUCTION 
Repetitive nucleotide sequences expand and contract via strand slippage during DNA 
replication and unequal crossing over during meiosis (Fig. 1)(Gemayel et al., 2010). Within 
the genome of the P. falciparum strain 3D7, repetitive sequences are found on average once 
every 467 nucleotides (Tan et al., 2010). These repeat encoding sequences tend to be highly 
dynamic; the rate of insertion and deletion mutations in genomes of parasites propagated in 
the asexual blood stage is approximately 10 fold greater than the rate of single base pair 
substitution (Hamilton et al., 2016) and within coding sequences, the majority of insertion 
and deletion mutations occur in short tandemly repeated sequences (Hamilton et al., 2016, 
Miles et al., 2016). The variability of these sequences is also highlighted by the observation 
that 9% of genes contain repetitive sequences that vary in length between P. falciparum 
strains 3D7, Dd2, and HB3 (Tan et al., 2010). Perfect repeats are predicted to have expanded 
more recently than degenerate repeats and are particularly common in Plasmodium species 
(Mendes et al., 2013). 
Many short tandemly repeated sequences within P. falciparum proteins are predicted to be 
intrinsically disordered (Feng et al., 2006, Guy et al., 2015). In isolation, such sequences are 
likely dynamic and do not fold into stably folded structures but exist as an ensemble of 
conformations (Oldfield and Dunker, 2014). In many cases, these sequences may not have a 
function per se but simply form disordered loops or termini protruding from folded domains. 
However, repeat sequences can also significantly change the properties of proteins and over 
evolutionary time expansion and contraction of repeats may fine-tune protein activity or even 
generate sequences de novo that can confer novel function. Indeed, low complexity 
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sequences, which include many repetitive sequences, are highly diverse. Whilst many are 
evolving neutrally others are likely under selective pressure (Battistuzzi et al., 2016, 
Zilversmit et al., 2010).  
Diverse functions for repetitive protein sequences in diverse 
organisms 
Functional repetitive proteins from many species have been extensively characterized and 
illustrate many of the concepts that will also apply to this class of polypeptides from 
Plasmodium. Stretches of single amino acid repeats are often prone to self-association, 
leading to the formation of protein aggregates or fibres (Oma et al., 2004). The detrimental 
effects of poly-glutamine and poly-alanine sequence aggregation are well-understood as they 
are associated with many human diseases (Gatchel and Zoghbi, 2005, Shoubridge et al., 
2007). Expansion of these repeat-encoding sequences increases their aggregation propensity 
and contributes to disease onset.  Expansion of single amino acid repeats is also important in 
non-pathological contexts; the activity of many yeast transcription factors can be fine-tuned 
over evolutionary time by expansion or contraction of poly-glutamine sequences (Gemayel et 
al., 2015). Artificial homo-polymeric sequences composed of different amino acids can direct 
proteins to different cellular compartments in mammalian cells (Oma et al., 2004) and poly-
histidine repeats in several human DNA-binding proteins can confer localization to nuclear 
speckles (Salichs et al., 2009). P. falciparum contains a striking number of asparagine-rich 
tracts; similar sequences have been shown to form fibres in yeast prion proteins which are 
believed to regulate protein activity and allow the cell to respond to environmental stimuli 
(Chernova et al., 2014, Halfmann et al., 2011, Halfmann et al., 2010, Peters and Huang, 
2007). 
Notably, there are several examples in which repeat length can influence the phenotype of an 
organism. For example, experimentally changing the number of repeats in the S. cerevisiae 
cell surface proteins Flo1p and Flo11p proportionally changes the adhesion and 
hydrophobicity of the cells, respectively (Fidalgo et al., 2006, Verstrepen et al., 2005). In the 
case of Flo1p, a central repeat sequence forms a linker that allows an N-terminal adhesion 
domain to extend away from the cell surface; expansion of this sequence increases the 
efficiency of cell adherence. The repetitive sequence in Flo11p is hydrophobic and repeat 
expansion therefore increases the overall hydrophobicity of the yeast cell surface, allowing 
cells expressing Flo11p with longer repeats to float on the surface of a liquid medium. Repeat 
sequences can also contribute to altered phenotypes in more complex organisms; changes in 
repeat sequences in morphogen proteins are likely responsible for some of the different 
morphological features that have been selected for in domesticated dogs (Fondon and Garner, 
2004, Fondon and Garner, 2007). 
These examples establish several key concepts: firstly, repeat sequences can be important for 
protein function per se; secondly, expansion or contraction of repetitive sequences can cause 
partial or complete loss or gain of a protein function; thirdly, changes in protein activity 
arising from changes to repeat length can cause phenotypic changes, the magnitude of which 
can be proportional to the repeat length; and finally, expansion and contraction of repeat 
sequences can potentially facilitate adaption of an organism over evolutionary time. 
Protein interactions and structures of repetitive protein sequences 
Although relatively few repetitive sequences from Plasmodium proteins have been 
extensively characterized many of the applicable concepts relating to their structure and 
function have been well established in the context of repetitive proteins from other organisms 
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(Andrade et al., 2001, Kajava, 2012). In isolation many repetitive sequences are intrinsically 
disordered but upon interaction with a binding partner will assume a structured conformation. 
The structural plasticity and repeating modular architecture of repetitive low complexity 
sequences results in binding interactions that can differ from those typically described for 
globular proteins.  
Repetitive protein sequences can potentially recruit multiple copies of an interacting partner. 
For example, multiple copies of transcriptional terminator proteins can interact cooperatively 
with neighbouring repeats in the C-terminal domain (CTD) of yeast RNA polymerase II 
(Lunde et al., 2010). Interaction with multiple copies of a binding partner can also increase 
interaction avidity. For example, the Staphylococcus aureus protein FnBPA contains short 
repeated motifs that interact with tandemly repeated β-sheet domains in human fibronectin. 
Although in isolation FnBPA repeats are intrinsically disordered, each repeat within a single 
FnBPA protein interacts with up to four consecutive fibronectin domains by contributing an 
additional β-strand to each domain (Bingham et al., 2008). As FnBPA contains multiple 
fibronectin-binding repeats it can interact with multiple fibronectin proteins which is 
important for adhesion to and invasion of endothelial cells (Edwards et al., 2010). 
Alternatively, multiple repeats within a sequence can simultaneously interact with a single 
non-repetitive protein as illustrated by the interaction of the RNA polymerase II CTD with 
the mediator complex; here the repeats interact with four structurally non-identical binding 
sites with each identical repeat assuming a different conformation (Robinson et al., 2012). In 
addition, the CTD of RNA polymerase II interacts with many other proteins in an 
orchestrated manner that is regulated by its post-translational modification. This illustrates 
the key paradigm that repetitive sequences can function as regulated protein interaction hubs 
(Cumberworth et al., 2013). In this context the role of the P. falciparum RNA polymerase II 
CTD is discussed in a later section. 
Although many repetitive sequences acquire structure only upon binding to a structured 
binding protein some form structured domains in isolation. For example, the repeated three 
amino acid motifs in collagen assemble to form a right-handed triple helix (Shoulders and 
Raines, 2009). Recent data also indicate that some repetitive sequences have a propensity to 
self-associate and undergo phase separation and thus partition into membraneless organelles 
within the cell (Kato et al., 2012). Although in most cases the functions and interactions of 
repetitive sequences in Plasmodium proteins are not well understood it is likely that these 
same principles will be relevant to many proteins that are expressed throughout the parasite 
lifecycle. 
THE MALARIA PARASITE LIFECYCLE 
Repetitive proteins are expressed throughout the malaria parasite lifecycle during which the 
parasite undergoes several differentiation steps within both insect and vertebrate hosts (Fig. 
2). The repetitive proteins discussed in this review, their repeat sequences, the variability of 
repeats between different P. falciparum strains, and time of expression during the lifecycle 
are summarized in table 1.  
An infection is initiated when haploid sporozoites are injected into the human host as a 
female Anopheles mosquito takes a blood meal. Having migrated via the bloodstream to the 
liver, sporozoites invade hepatocytes and multiply into thousands of haploid merozoite forms 
before being released back into the blood (reviewed in (Lindner et al., 2012)). The released 
merozoites invade erythrocytes and replicate intracellularly (reviewed in (Cowman et al., 
2016)). After replication within the erythrocyte, daughter merozoites egress and after a brief 
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extracellular period invade new erythrocytes, undergoing further rounds of replication, egress 
and reinvasion. During the blood stage a fraction of the parasite population becomes 
committed to differentiate into gametocytes, the sexual stage of the parasite lifecycle. 
Gametocytes can be taken up by a mosquito during a blood meal (reviewed in (Bennink et al., 
2016)). Within the mosquito midgut male gametocytes undergo exflagellation to form motile 
microgametes and female gametocytes form macrogametes. Gamete fusion leads to 
formation of a diploid zygote that differentiates into a motile ookinete which penetrates the 
mosquito midgut and forms an oocyst. Haploid sporozoites develop within the oocyst and are 
eventually released into the mosquito hemolymph before travelling to the salivary glands 
from where they can be injected into the next host (reviewed in (Aly et al., 2009)). After 
gamete fusion the parasite is briefly diploid but following a meiotic division the parasite 
returns to a haploid state and replicates mitotically for the remainder of the lifecycle. It is 
likely that expansion and contraction of gene sequences encoding repetitive proteins occurs in 
both meiotic and mitotic phases of the lifecycle. 
 
FUNCTIONS OF REPEAT PROTEINS ON THE PARASITE 
SURFACE, WITHIN THE PARASITE AND IN THE 
INTERACTION WITH HOST CELLS 	
Whilst many proteins expressed throughout the lifecycle contain repetitive sequences the 
roles of these sequences are in most cases poorly understood. In the following sections we 
will discuss how repetitive proteins interact with the host immune system as well as specific 
proteins and groups of proteins where the function or importance of repeat sequences have 
been established. 
 
Repetitive Plasmodium proteins and the immune response 
Within the human host many repetitive parasite proteins are recognised by the immune 
system. 79% of tandem repeats in parasite proteins fall within protein sequences predicted to 
be intrinsically disordered (Guy et al., 2015). These sequences, in comparison to those from 
globular folded proteins, have a biased amino acid composition which results in fewer 
predicted MHCI and II peptides but a greater number of predicted B-cell epitopes (Guy et al., 
2015, Hughes, 2004, Verra and Hughes, 1999). Notably, antibody interactions with 
disordered epitopes are predicted to be more sensitive to epitope sequence changes than 
interactions with structured epitopes. Given the propensity of disordered sequences to tolerate 
sequence polymorphism, this may allow effective evasion of antibody responses against these 
sequences (MacRaild et al., 2016).  
Although sera from individuals living in endemic regions contain high levels of antibodies 
against repetitive proteins it is unclear whether these confer protection against disease. It has 
been speculated that repetitive proteins can even be detrimental to an effective immune 
response by crosslinking B-cell receptors and inducing an inferior T-cell independent 
immune response (Schofield, 1991). Although the antibody responses to most Plasmodium 
repetitive antigens have not been characterized, in mice there is a T-cell independent B-cell 
response to a repetitive sequence in the circumsporozoite protein (discussed later) but the 
bulk of the B-cell response is T-cell dependent (Fisher et al., 2017). It has also been proposed 
that repetitive antigens can generate an ‘antigenic smokescreen’ in which numerous cross-
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reactive repetitive antigens interfere with the affinity maturation of antibodies against 
protective antigens (Kemp et al., 1987).  
Nonetheless, many repetitive sequences are recognised by the immune system, and in 
particular those located on the parasite surface potentially represent important vaccine 
components and targets of host immunity. For the majority of the forty eight hour asexual 
replication cycle in the blood stage the parasite resides within the host erythrocyte. However, 
after egress merozoites are extracellular for up to several minutes before they invade new 
erythrocytes. During this period many repetitive merozoite surface proteins including MSP1, 
MSP2, GLURP, and SERA5 (SERA5 is a parasitophorous vacuole protein important for 
egress (Collins et al., 2017) but remains associated with the merozoite surface (Li et al., 
2002)) and others are exposed to the host immune system (Beeson et al., 2016). SERA5 
antibodies isolated from serum of Ugandan adults predominantly recognise the repetitive 
sequences within the protein and also show parasite growth inhibition in vitro in the presence 
of monocytes (Yagi et al., 2014). Similarly, antibodies that recognise the repetitive sequences 
in MSP1 and GLURP also show parasite growth inhibition (Galamo et al., 2009, Theisen et 
al., 1998). Alleles of the repetitive sequence in MSP1 appear to be under balancing selection 
which is consistent with this sequence being under immune selection (Conway et al., 2000). 
The repeating motifs of both MSP1 and MSP2 vary between isolates (Table 1), suggesting 
that there is not a strong functional constraint on these sequences and that they might easily 
change in response to immune pressure. 
Circumsporozoite protein (CSP) is the major protein on the surface of the sporozoite which is 
also extracellular in the human host (Sinnis and Nardin, 2002). Both T-cell and antibody 
responses are elicited against CSP during infection. The RTS,S vaccine, which is currently 
the most successful malaria vaccine, provides partial protection against disease (Hoffman et 
al., 2015, Rts, 2015) and is based on a fragment of the circumsporozoite protein comprising 
tandemly repeated NANP motifs and a C-terminal domain. The central repetitive sequence 
contains immunodominant antibody epitopes (Zavala et al., 1985). Significantly, the repeat 
sequence in CSP is variable between parasite species. The repeating sequence motif in P. 
berghei CSP differs from those found in the P. falciparum and P. vivax proteins but despite 
this the repeat sequence from P. berghei CSP can be replaced with the repeat sequence from 
the P. vivax or P. falciparum protein without compromising function (Espinosa et al., 2013, 
Persson et al., 2002). Also, the number of repeats varies from 37 to 44 in different strains of 
P. falciparum (Neafsey et al., 2015). Although variation in the number of repeat units in CSP 
does not significantly affect vaccine efficacy (Neafsey et al., 2015) significant sequence 
variation can clearly be tolerated in the repeat sequences and their mutation may allow the 
parasite to evade B-cell responses without disrupting the function of CSP. 
 
Circumsporozoite protein – a repetitive sequence essential for 
sporozoite development 
Circumsporozoite protein, which is essential for parasite survival (Ferguson et al., 2014), is 
linked via a C-terminal glycophosphatidylinositol (GPI) anchor to the sporozoite plasma 
membrane. It consists of an N-terminal domain that binds heparin sulphate proteoglycans, a 
repeating central sequence, and a C-terminal Thrombospondin repeat domain (Sinnis and 
Nardin, 2002). Deletion of the central repeating sequence in the P. berghei CSP gene leads to 
a defect in sporozoite development in the mosquito. Although oocyst formation appears to be 
normal, the development of sporozoites is defective and sporozoites fail to appear in either 
the hemolymph or salivary glands of the mosquito (Ferguson et al., 2014).  
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While many repetitive sequences are predicted to be entirely disordered, biophysical analyses 
are consistent with the CSP repeats adopting an elongated but flexible cylinder-like structure 
that is about 18nm in length and 1.5nm in diameter and composed of β-turn structures 
(Plassmeyer et al., 2009). The model is based on the propensity of short NANP peptides to 
adopt a β-turn conformation (Ghasparian et al., 2006, Nanzer et al., 1997). NMR and circular 
dichroism studies suggest that CSP repeat peptides are in equilibrium between folded and 
extended states (Dyson et al., 1990, Fisher et al., 2017). Consistent with this, experiments 
examining the force required to unfold the CSP repeat region support a model in which CSP 
repeats can exist in a state that is partially structured, requiring relatively low force to unfold; 
or in an unstructured state which requires almost no force to unfold (Patra et al., 2017). 
Antibody accessibility studies also support a model in which CSP is conformationally 
dynamic undergoing significant conformational changes in the oocyst, mosquito salivary 
gland, and human liver (Coppi et al., 2011, Herrera et al., 2015). The CSP repeat structure 
may serve to extend the N-terminal domain away from the plasma membrane of the parasite. 
It is possible that deletion of the repeat sequence (Ferguson et al., 2014) results in a shorter 
rod-like structure or alternatively it may prevent the entire protein from folding correctly. 
Such differences in an important protein on the surface of the sporozoite may be detrimental 
to development in the mosquito. 
Liver stage antigen-1 – a network of covalently crosslinked 
repeats 
Liver stage antigen-1 is localised in the parasitophorous vacuole during the liver stage of the 
lifecycle and is required for progression of P. falciparum through this stage (Fidock et al., 
1994, Mikolajczak et al., 2011). The repeats in Liver stage antigen-1 are rich in glutamine 
and lysine residues and are an in vitro substrate for transglutaminase which catalyses the 
covalent crosslinking of polypeptides. Although transglutaminase-crosslinked peptides can be 
detected in liver stage parasites by microscopy, it is unclear whether LSA-1 itself is 
crosslinked in vivo (Nicoll et al., 2011), and whether this is important for liver-stage 
development. 
 
RNA Polymerase – a hub for regulated recruitment of binding 
partners 
In eukaryotes, three different RNA Polymerases (RNA Pol) are required to transcribe the 
nuclear genome; RNA Pol I transcribes ribosomal RNA (rRNA), RNA Pol II transcribes 
messenger RNA (mRNA) and RNA Pol III transcribes 5S rRNA and transfer RNA (tRNA) 
(Vannini and Cramer, 2012). As discussed previously, the C-terminus of the largest subunit 
(RbpI) of RNA Pol II  contains a repetitive sequence known as the C-terminal Domain (CTD) 
(Corden et al., 1985). This domain consists of a tandemly repeated Tyr-Ser-Pro-Thr-Ser-Pro-
Ser/Lys sequence which undergoes reversible phosphorylation during the transcription 
cycle. Changes in the phosphorylation pattern of repeats within the CTD are thought to 
orchestrate the recruitment of various nuclear factors that couple processing of the nascent 
mRNA to transcription (Howe, 2002)(Fig. 3).  
The CTD is essential for cell viability in yeast, drosophila and mice (Litingtung et al., 1999, 
Nonet et al., 1987, Zehring et al., 1988).  The overall length or number of the heptad repeats 
is also important as decreasing the number of repeats in the CTD of yeast from 26 to below 8 
causes loss of viability (West and Corden, 1995). Although small truncations of the yeast 
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CTD are tolerated, these result in reduced transcript levels of certain genes. Truncation of the 
CTD in yeast to 17, 14, 13 and 11 repeats leads to the production of 58%, 8%, 5% and 2% of 
normal transcript levels of specific genes, respectively, signifying the importance of the 
repetitive nature of the CTD (Liao et al., 1991).   
Although the consensus sequence and number of heptad repeats in RNA pol II varies from 
one organism to another, it is strictly conserved along evolutionary lineages; for example all 
mammalian CTDs possess 52 heptapeptide repeats with little variation in the consensus 
(Chapman et al., 2008). Strikingly, there is considerable variation in the number of repeats 
found across the Plasmodium genus. Rodent and bird-infecting species, including P. berghei 
and P. gallinaceum, respectively, possess 8 repeats, while the CTD of some primate-infecting 
species has expanded resulting in 13-15 repeats. This expansion appears to have arisen twice 
during Plasmodium evolution; once in the lineage that has given rise to P. falciparum and 
once in the lineage that has given rise to P. vivax (Kishore et al., 2009).  Primate infecting 
parasites appear to have preferentially expanded a heptad repeat containing a lysine residue in 
the 7th position (Kishore et al., 2009). Furthermore, this plasticity extends not only to 
different Plasmodium species but also to different isolates within a given species, making 
Plasmodium one of the few organisms that show intra-species variation in the number of 
heptad repeats in its RNA pol II CTD (Kishore et al., 2009). Although the significance of the 
repeat expansions is unclear it has been suggested that repeat expansion may confer 
additional functions to the CTD (Ukaegbu and Deitsch, 2015).  
In higher eukaryotes, it is known that the CTD recruits proteins with diverse roles in 
transcription and gene expression. These include factors such as histone modifying enzymes 
(Yoh et al., 2008). The CTD of P. falciparum RNA pol II interacts with PfSET2 (also 
referred to as PfSETvs), a histone methyl transferase which tri-methylates histone H3 at 
lysine 36 (H3K36me3) (Cui et al., 2008, Jiang et al., 2013, Ukaegbu et al., 2014). This 
histone modification is found in telomeric and subtelomeric chromatin and associated with 
genomic regions encoding the PfEMP1 var gene family (Jiang et al., 2013, Ukaegbu et al., 
2014). Although there are more than 60 var genes in the P. falciparum genome, mRNA from 
only a single var gene is produced at any one time and consequently a single PfEMP1 protein 
is displayed on the surface of an infected erythrocyte. By switching var gene expression the 
parasite is able to evade an immune response directed against a particular PfEMP1 protein. 
Although mRNA from only a single var gene is transcribed at any one time the RNA pol II 
also transcribes non-coding RNAs from var genes. It is likely that RNA pol II recruits 
PfSET2 to var genes during the latter process. Although the precise mechanism by which 
PfSET2 and H3K36 tri-methylation regulates var gene silencing is unclear, deletion of 
PfSET2 or expression of a dominant-negative version of PfSET2 which interacts with the 
RNA pol II CTD, result in dis-regulation of var gene expression, strongly indicating a role 
for the CTD and its interacting partner PfSET2 in this process (Jiang et al., 2013, Ukaegbu et 
al., 2014). 
Homopolymeric Asparagine-rich repeats and protein aggregation 
One of the best studied examples of repetitive protein sequences modulating protein 
properties comes from the study of poly-glutamine (Gln) tracts. Expansion of these 
homopolymeric tracts leads to protein aggregation and is associated with ‘poly-glutamine 
diseases’ such as Huntington’s disease in humans (Gatchel and Zoghbi, 2005). However, it 
has also been proposed that such poly-Gln repetitive sequences modulate protein function and 
that expansion and contraction of repeats may fine-tune protein function and phenotype over 
evolutionary time (Gemayel et al., 2015). 
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Single amino acid repeats of the amino acid asparagine (Asn) are prevalent in the P. 
falciparum genome. Like poly-Glutamine sequences, poly-Asn sequences are also prone to 
aggregation particularly at elevated temperatures (Halfmann et al., 2011) which the parasite 
would experience during fever. Given that protein aggregation is often toxic to cells it is 
remarkable that the parasite proteome maintains so many potentially toxic Asn-rich repeats; 
more than a quarter of its proteins contain such sequences.  Expression of a GFP-tagged 
version of the Asn-rich protein from P. falciparum, PF3D7_0923500, in human cells leads to 
accumulation of fluorescent protein aggregates as does expression of the N-terminal prion 
forming domain of S. cereviasiae asparagine/glutamine-rich Sup35 (Muralidharan et al., 
2012). Co-expression of the human Hsp110 or Plasmodium homologue PfHsp110c inhibits 
aggregate formation; PfHsp110c does so approximately 10-15 fold more efficiently than the 
human chaperone (Muralidharan et al., 2012). This suggests that Plasmodium chaperones 
may be particularly efficient at suppressing the aggregation of Asn-rich repeat sequences. 
Although PfHsp110c is essential for survival, a reduction of expression leads to increased 
aggregation of Asn-rich proteins and parasites cannot recover from short periods of heat 
shock (Muralidharan et al., 2012). These data are consistent with a model in which 
PfHsp110c plays a key role in maintaining the solubility of Asn-rich proteins under heat 
shock conditions (Muralidharan et al., 2012). 
The function of Asn-rich repeats in the parasite is unclear and in many cases these sequences 
have likely evolved without cost or benefit. Notably, deletion of the Asn-rich repeat sequence 
in the proteasome protein Rpn6 does not compromise its function (Muralidharan et al., 2011). 
However, several transcription factors in S. cerevisiae contain poly-glutamine repeats and 
variation of the repeat length can fine-tune transcription of target genes and resulting 
phenotypes (Gemayel et al., 2015). This is at least partially due to changes in protein 
solubility and interaction partners. Notably, the majority of AP-2 transcription factors 
encoded in the parasite genome have very high asparagine content of between 20% and 30%. 
The P. falciparum protein AP2-g, which triggers the transition to gametocytogenesis 
(Kafsack et al., 2014, Sinha et al., 2014), comprises 2432 residues, 29.9% of which are 
asparagine. Asparagines are found both in homopolymeric repeats, the longest of which is 33 
residues in length, as well as in short tandemly repeated sequences. It is unclear if variations 
in the AP2-g Asn-rich repeats seen in different strains (Campino et al., 2016) fine tune its 
solubility/activity and hence the propensity of parasites to form gametocytes. Changes in 
Poly-Asn sequences in other AP2 transcription factors might also modulate their activity 
leading to small changes in progression through the lifecycle; even small delays in the 
asexual cycle of the parasite could lead to a selective advantage. Additionally, given the 
propensity of asparagine-rich repeats to aggregate, particularly under heat shock, it is possible 
that solubility/activity of transcription factors might change during fever. 
Asparagine repeats and protein translation 
The rate of translation of a protein is determined by the concentration of available 
aminoacylated tRNAs. Given the unusually high occurrence of asparagine residues in the P. 
falciparum genome, particularly in long low complexity repetitive sequences, the parasite 
might require large amounts of Asn:tRNA to efficiently translate Asn-rich proteins. In many 
organisms there is redundancy in the genes encoding tRNAs for each amino acid. For 
example, in C. elegans there are 46 genes encoding tRNAs that recognise the four glycine 
codons (Duret, 2000). Given the abundance of Asn in encoded proteins, it might be expected 
that the P. falciparum genome would encode multiple tRNAs that recognize Asn codons thus 
allowing the parasite to make high levels of Asn:tRNA. However, only a single gene encodes 
Asn:tRNA (Gardner et al., 2002) and levels of Asn:tRNA are not proportionally more 
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abundant. This has led to a model in which translation is slowed down when the ribosome 
encounters long low complexity Asn-repeat sequences due to the relatively lower 
concentrations of Asn-tRNA (Filisetti et al., 2013, Frugier et al., 2010). This could slow the 
rate of polypeptide emergence from the ribosome tunnel and allow N-terminal domains that 
have already been synthesised more time to fold before emergence of subsequent domains. 
This may increase the overall efficiency of protein folding.  
 
MODIFICATION OF THE HOST ERYTHROCYTE BY 
REPETITIVE EXPORTED PROTEINS 
The human erythrocyte is a relatively simple terminally differentiated cell that lacks internal 
organelles. During the blood stage of infection the parasite profoundly remodels its host cell, 
establishing new permeability pathways for acquiring nutrients, modifying the erythrocyte 
cytoskeleton to increase rigidity, and generating knob-like structures on the surface of the 
host cell which allow infected cells to cytoadhere to endothelial cells in the microvasculature 
(Boddey and Cowman, 2013, de Koning-Ward et al., 2016, Przyborski et al., 2016, 
Spielmann and Gilberger, 2015, Spillman et al., 2015). The parasite brings about these 
changes by exporting over 400 proteins into the host cell; these proteins can be localised to 
the erythrocyte cytoplasm, plasma membrane, the underlying spectrin cytoskeleton, or to 
Maurer’s clefts which are membranous structures assembled by the parasite (Fig. 4). Many 
exported proteins are characterized by the presence of an N-terminal signal sequence 
followed by a short motif referred to as a Protein Export Element (PEXEL) or Host targeting 
motif (HT) (Boddey et al., 2013, Hiller et al., 2004, Marti et al., 2004, Schulze et al., 2015). 
Another class of exported proteins lack a PEXEL sequence and are referred to as PEXEL 
negative exported proteins (PNEPS) (Heiber et al., 2013). Notably, many exported proteins 
contain repetitive sequences that play key roles in diverse processes including cytoadhesion, 
formation of Maurer’s clefts, protein localisation, and detoxification of heme (Fig. 4). 
Lysine-rich repeats in exported proteins – Changes in repeat 
length can influence protein localization 
There are several examples of repetitive proteins, such as the yeast proteins Flo1p and Flo11p 
(discussed in previous section), where the function of the protein can be proportionally 
modulated by repeat length (Fidalgo et al., 2006, Verstrepen et al., 2005). It is conceptually 
clear in such cases how relatively small changes in the number of tandemly repeated 
sequences could be important in facilitating adaption of an organism to its environment. In 
Plasmodium, many proteins including exported proteins, contain low complexity lysine-rich 
repetitive sequences. In some cases these sequences are adjacent to a folded domain but they 
can also be found in proteins that are predicted to be entirely intrinsically disordered. In 
several proteins which are exported into the host cell by a PEXEL motif, lysine-rich 
sequences can target the protein to the periphery of the infected erythrocyte (Davies et al., 
2016). Comprising relatively simple tandemly repeated motifs of as few as three residues 
(e.g. Lys-Lys-Glu), these sequences are likely to interact with either lipids or proteins in the 
erythrocyte plasma membrane or the underlying erythrocyte spectrin cytoskeleton.  
The exported P. falciparum protein glutamic acid-rich protein (GARP) contains multiple 
lysine-rich sequences that function in this manner. Significantly, the targeting propensity of a 
repetitive lysine-rich sequence from GARP is proportional to its length - increasing the 
number of tandemly repeated sequences proportionally shifts the protein from being diffusely 
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localised in the erythrocyte cytoplasm to being highly concentrated adjacent to the plasma 
membrane of the infected cell (Fig. 5) (Davies et al., 2016). At least nine exported parasite 
proteins contain lysine-rich sequences that independently target to the periphery of the 
erythrocyte. The lengths of repeating lysine-rich sequences from many of these exported 
proteins vary between parasite strains (Davies et al., 2016). Additionally, in the protein 
MESA, a block of sequence made up of tandemly repeated lysine-rich motifs has itself been 
duplicated with two to four copies of the sequence in different parasite strains (Davies et al., 
2016). Although the phenotypic consequences of repeat expansion and duplication have not 
been determined experimentally, several of these proteins are known to modulate rigidity and 
adhesion of infected cells. Given this, expansion and contraction of lysine-rich sequences 
may proportionally change the concentration of proteins localised to the periphery of the host 
cell, fine-tuning processes such as cell rigidity or adhesion, and facilitating adaption of the 
parasite to selective pressure over evolutionary time. 
A comparison of the protein sequence of GARP from three different species, P. falciparum, 
P. reichenowi, and P. gaboni, indicates that repeat expansion can also lead to de novo 
formation of a targeting domain (Davies et al., 2016). There are three stretches of lysine-rich 
repetitive sequence within P. falciparum GARP. The first sequence in the P. falciparum 
protein is able to target a GFP reporter to the periphery of the host cell. However, the 
equivalent lysine-rich sequence in the P. reichenowi protein is shorter and does not efficiently 
target to the periphery of the host cell. The second lysine-rich sequence is conserved and is 
likely to be functional in all three species. The third lysine-rich sequence, that comprises two 
different repeated motifs in P. falciparum GARP, can target a protein to the erythrocyte 
periphery but the equivalent sequence in P. gaboni comprises only one or two repeated 
lysine-rich motifs and cannot target GFP to the periphery of the infected erythrocyte. These 
observations show not only that repeat expansion of lysine-rich sequences can modulate 
protein localization but also that functional targeting sequences can be generated de novo by 
repeat expansion over evolutionary time.  
The localisation of Hyp12 (PF3D7_1301400), which modulates the rigidity of the infected 
cell (Maier et al., 2008), appears to be defined by two conflicting sequences; a repetitive 
lysine-rich sequence and a repetitive acidic sequence (Davies et al., 2016). Hyp12 is unusual 
in that the lysine-rich repeat sequence alone is able to target GFP to the periphery of the 
infected cell but the GFP-tagged full-length protein is localised in the erythrocyte cytoplasm 
(Davies et al., 2016, Petersen et al., 2015). Removal of the acidic sequence results in the 
protein being localised to the red cell periphery suggesting that the acidic sequence inhibits 
the targeting function of the lysine-rich repeat sequence. It is possible that a specific stimulus 
might unmask the sequence during an infection. Over evolutionary time, it is likely that either 
expansion of the lysine-rich region or contraction of the acidic sequence could shift the 
protein from the erythrocyte cytoplasm to the periphery of the erythrocyte. 
Knob-associated histidine-rich protein – repeat protein 
interactions and parasite virulence 
Knob-associated histidine-rich protein (KAHRP) is one of the best-characterised repeat-
containing proteins. It is a key component of structured spiral-like ‘knob’ protrusions which 
the parasite assembles at the surface of the infected erythrocyte (Crabb et al., 1997, 
Watermeyer et al., 2016). Knobs are involved in displaying PfEMP1 proteins on the surface 
of the infected cell where they mediate adhesion to specific ligands allowing parasites to 
become sequestered in tissues thus avoiding passage through the spleen (Crabb et al., 1997). 
KAHRP interacts with the host cytoskeletal components spectrin (Kilejian et al., 1991, Pei et 
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al., 2005) and ankyrin (Weng et al., 2014) and deletion of the gene causes a loss of knob 
structures, decreases adhesion under flow conditions (Crabb et al., 1997), and reduces 
erythrocyte rigidity (Glenister et al., 2002). KAHRP contains an N-terminal repetitive poly-
histidine stretch that will target GFP to the periphery of the infected erythrocyte (Rug et al., 
2006). It also has two unique lysine-rich repetitive regions, known as the 5’ and 3’ repeats; 
only the 5’ repeat sequence is sufficient to independently target GFP to the erythrocyte 
periphery (Davies et al., 2016). Progressive truncation of the C-terminus of KAHRP indicates 
that the 5’ repeats are important for the role of KAHRP in cytoadhesion (Rug et al., 2006). 
Several studies indicate that these repeats interact with spectrin (Cutts et al., 2017, Kilejian et 
al., 1991, Pei et al., 2005). Most recently, it has been demonstrated in vitro that the repeats 
interact with β-spectrin domains 10-14 and more weakly with α-spectrin domains 12-16. 
Significantly, progressive removal of repeats from the KAHRP repeat sequence leads to a 
corresponding reduction of binding affinity for β-spectrin domains 10-14  i.e. the binding 
affinity is proportional to the number of KAHRP repeats (Fig. 5) (Cutts et al., 2017). This 
again highlights the potential importance of repeat expansion and contraction in modulating 
protein function. Modelling and molecular dynamics simulations support a model whereby 
the KAHRP repeats adopt an extended conformation of the surface of spectrin, interacting 
with charge complementary surfaces on multiple β-spectrin domains (Cutts et al., 2017). 
Although knob structures are unique to P. falciparum, KAHRP-like proteins are found in all 
primate-infecting Plasmodium species (Davies et al., 2016, Sargeant et al., 2006). These 
proteins share an N-terminal EKAL domain (EMP3 KAHRP-like domain) followed by 
lysine-rich repeating sequences but the function of the proteins in other species is not known. 
The repeated lysine-rich motifs in the P. falciparum and P. knowlesi proteins both contain 
consecutive lysine residues but otherwise differ significantly. However, when expressed in P. 
falciparum, both can target a protein to the periphery of the infected cell (Davies et al., 2016). 
It is likely that both these repetitive lysine-rich sequences interact with a negatively charged 
surface on spectrin. Presumably the binding interface can tolerate somewhat diverse 
conformations of positively charged interacting peptides. Notably, there does not appear to be 
a strong consensus sequence among all of the different lysine-rich targeting sequences 
identified thus far. Identification of the binding partners, which could be proteins or lipids, 
for each protein and further structural studies will be required to understand the functions of 
these diverse repetitive sequences.  
Although KAHRP contains a conserved EKAL domain of unknown function at its N-
terminus (Davies et al., 2016, Sargeant et al., 2006), the remainder of the protein is predicted 
to be intrinsically disordered and much of the sequence is repetitive. Likewise, PfEMP3 
contains a conserved N-terminal EKAL domain and several different repetitive sequences at 
its C-terminus but the repetitive sequences are very different from those of KAHRP. It is 
likely that the PfEMP3 gene arose as a duplication of the KAHRP gene or vice versa yet gene 
knockout and functional studies show that the two proteins are not functionally equivalent 
(Crabb et al., 1997, Glenister et al., 2002, Waterkeyn et al., 2000). Likely, after gene 
duplication the dynamic repetitive sequences have diverged dramatically and consequently 
the function of the two proteins has likewise also diverged. The dynamic nature of repetitive 
sequences together with the telomeric location of many of the genes encoding exported 
proteins suggests that gene duplication and rapid diversification have occurred frequently 
during the evolution of the parasite; repeat expansion likely plays an important role in the 
latter process. 
PHIST/PRESAN domain proteins  
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A large group of functionally diverse exported parasite proteins belong to the PHIST 
(Plasmodium helical interspersed subtelomeric) or PRESAN (Plasmodium RESA N-terminal) 
domain family (Oakley et al., 2007, Sargeant et al., 2006, Warncke et al., 2016). The proteins 
are characterized by the presence of a conserved alpha helical domain (Mayer et al., 2012) 
and are exported into the infected erythrocyte during the asexual erythrocyte stages and 
during gametocytogenesis (Oakley et al., 2007, Sargeant et al., 2006, Silvestrini et al., 2010, 
Tiburcio et al., 2015). One of the best characterised proteins in this family is LyMP (lysine-
rich membrane-associated PHISTb), which modulates erythrocyte cytoadhesion by linking 
PfEMP1 to the erythrocyte cytoskeleton (Oberli et al., 2014, Oberli et al., 2016, Proellocks et 
al., 2014, Tarr et al., 2014). LyMP contains an N-terminal PHIST/PRESAN domain, which 
interacts with the cytoplasmic tail of PfEMP1 (Oberli et al., 2014), and a C-terminal sequence 
that interacts with the erythrocyte cytoskeletal protein Band 3 (Oberli et al., 2016).  The 
extreme C-terminus of LyMP contains a lysine-rich repetitive sequence which when GFP-
tagged and exported into the erythrocyte is sufficient to localise to the erythrocyte periphery 
(Davies et al., 2016). Although the fragment of LyMP that has been shown to interact with 
Band 3 in vitro contains the lysine-rich sequence, it is unclear whether this sequence interacts 
with Band 3 or another component of the erythrocyte cytoskeleton. 
LyMP is an example of a gene that encodes a folded domain (PHIST/PRESAN domain) but 
has expanded a repetitive lysine-rich sequence which likely allows the encoded protein to 
interact with an additional protein. Similarly, GEXP12, PF3D7_1201000, PF3D7_1476200, 
and	PF3D7_0402000 contain a PHIST/PRESAN domain but also contain lysine-rich 
sequences that alone localise to the periphery of the infected erythrocyte (Davies et al., 2016). 
The PHIST/PRESAN domain of PF3D7_0402000 interacts with Band 4.1 and ankyrin that 
are components of the erythrocyte cytoskeleton (Parish et al., 2013, Shakya et al., 2017, 
Vignali et al., 2008), but the protein also contains a C-terminal lysine-rich repetitive targeting 
sequence (Davies et al., 2016). Other PHIST/PRESAN proteins, such as PFD80 (Tarr et al., 
2014) and RESA (Ring expressed surface antigen) (Brown et al., 1985) localize to the 
erythrocyte cytoskeleton, and have expanded repetitive sequences that are not lysine-rich and 
do not independently confer a cytoskeletal localization. RESA modulates the rigidity of the 
infected cell and deletion of the gene does not affect cytoadhesion (Maier et al., 2008). 
Although the role of PFD80 is unclear it is likely essential as attempts to delete the gene have 
been unsuccessful (Maier et al., 2008). The localization and likely functions of PHIST 
proteins are diverse and in most cases the functions of their repetitive sequences are unclear. 
However, as with KAHRP and PfEMP3, it is possible that the functions of the protein family 
members have been diversified by duplication of genes encoding a protein with a conserved 
domain followed by expansion of different repetitive sequences which may contribute to 
modulating or changing the function of the protein. 
Repetitive Maurer’s cleft proteins  
There are numerous exported proteins with repetitive sequences that are not lysine-rich. In 
some cases the function of these sequences is well understood. Ring exported protein-1 
(REX1) is a PEXEL negative exported protein which has a repetitive sequence that is 
essential for protein function (McHugh et al., 2015). The protein is peripherally associated 
with Maurer’s clefts (Hawthorne et al., 2004) which are flattened membrane vesicles in the 
infected erythrocyte and are essential for the trafficking of PfEMP1 to the surface of the 
infected erythrocyte. Deletion of genes encoding several Maurer’s cleft proteins disrupts 
PfEMP1 trafficking (Cooke et al., 2006, Maier et al., 2007, Rug et al., 2014, Spycher et al., 
2008).  
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Deletion of the repetitive region of REX1 (residues 371 - 579) reduces the number of 
Maurer’s clefts detected in the erythrocyte. On average 13 punctae corresponding to Maurer’s 
clefts are seen in erythrocytes infected with wildtype parasites but only 2 large punctae are 
seen in cells infected with parasites expressing REX1 that is missing the repetitive sequence 
(McHugh et al., 2015). Electron microscopy reveals that these Maurer’s clefts have an 
unusual stacking phenotype with an average of six clefts stacked on top of each other.  
(McHugh et al., 2015). Although PfEMP1 is trafficked to the abnormal stacked Maurer’s 
clefts, transfer to the erythrocyte plasma membrane is less efficient when REX1 is either 
knocked down or the repetitive region is deleted (McHugh et al., 2015). Removal of the 
repetitive region also reduces the adhesion of infected erythrocytes to CD36 cells under flow 
conditions (McHugh et al., 2015). This indicates that the repetitive region of REX1 is 
functionally important for both Maurer’s cleft architecture and efficient trafficking of 
PfEMP1. It is unlikely that the repeat region is simply forming a linker sequence between the 
N- and C-termini of the protein, as the C-terminal residues are not required for protein 
function and can be deleted. This suggests that the repeat sequences play an active role in 
protein function, possibly forming a key structural element or recruiting other proteins to the 
Maurer’s cleft membrane. Notably, the sequence and length of the repetitive domain varies 
between different parasites; this could contribute to the formation of stacked cleft structures 
in some strains (Wickert and Krohne, 2007) and may modulate the propensity of parasites to 
cytoadhere (McHugh et al., 2015).  
Skeleton binding protein-1 (SBP1) is an exported PNEP which contains a single 
transmembrane segment which is integrated within the Maurer’s cleft membrane. Deletion of 
the gene results in reduced trafficking of PfEMP1 to the erythrocyte surface and reduced 
cytoadhesion (Chan et al., 2016, Cooke et al., 2006, Maier et al., 2007). SBP1 contains 
repetitive sequences located N- and C-terminally on either side of the transmembrane 
segment. The N-terminal repeats can self-associate (Saridaki et al., 2009) while the 
glutamine-rich repeats at its C-terminus associate with the cytoskeletal components spectrin 
and 4.1 in vitro (Kats et al., 2015). Although these interactions likely contribute to the 
tethering of Maurer’s clefts to the erythrocyte cytoskeleton, the C-terminus of SBP1 can be 
replaced by an unrelated protein sequence without altering the location of Maurer’s clefts or 
cytoadhesion of infected cells. However, as it is known that there are multiple mechanisms 
for tethering of Maurer’s clefts there may be redundancy in this function of SBP1 (Cyrklaff et 
al., 2011, Hanssen et al., 2010, Pachlatko et al., 2010, Rug et al., 2014).  
Pf332 is a large exported protein that localises to Maurer’s clefts and is mainly composed of 
several different glutamate-rich repeats. Pf332 deletion and truncation of its repetitive C-
terminus have been shown to have varying effects on the rigidity and cytoadhesion of 
infected cells; differences between studies may be a result of using different parasite strains 
and the particular deletion strategies (Glenister et al., 2009, Hodder et al., 2009). 
 
Exported Repetitive histidine-rich proteins 
Histidine-rich Protein 2 (HRP2) is a P. falciparum protein comprised almost entirely of 
repetitive Histidine-rich sequences. HRP2 is exported into the erythrocyte cytoplasm during 
the blood stage of infection and released into the blood during parasite egress (Howard et al., 
1986) where it can accumulate to high levels (Ramutton et al., 2012). Several functions for 
HRP2 have been proposed including the detoxification of heme. The parasite internalizes 
haemoglobin from the cytoplasm of the host erythrocyte and digests it within the food 
vacuole; a fraction of HRP2 is also localised in the food vacuole (Papalexis et al., 2001, 
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Sullivan et al., 1996). Within the food vacuole the toxic heme moiety, a by-product of 
haemoglobin degradation, is converted into inert hemozoin. In vitro, HRP2 is able to catalyse 
the conversion of heme to hemozoin as is a similar histidine-rich repetitive protein HRP3 
(Sullivan et al., 1996). HRP2 is also able to promote the degradation of heme (Papalexis et 
al., 2001). However, P. falciparum parasites lacking genes encoding both HRP2 and HRP3 
are able to produce hemozoin suggesting that there are multiple mechanisms by which 
hemozoin is generated in vivo or that HRP2 plays a relatively minor role in this process. 
Indeed, other protein-based (Jani et al., 2008, Sullivan et al., 1996) and non-protein based 
mechanisms have been proposed (reviewed in (Egan, 2008)). 
HRP2 has also been implicated in regulation of thrombin inhibition (Ndonwi et al., 2011). In 
vitro, anti-thrombin inhibits the activity of thrombin and factor 10a and the inhibition is 
potentiated by glycosaminoglycans such as heparin. The potentiation can be antagonized by 
the interaction of HRP2 with glycosaminoglycans (Ndonwi et al., 2011). Thus HRP2 may 
behave as a pro-coagulant during infection. 
More recent studies indicate that HRP2 may play a role in cerebral malaria by disrupting the 
integrity of brain endothelial cell barriers. Using a system that comprises an in vitro cultured 
monolayer of human endothelial cells which mimics the blood brain barrier, it has been 
shown that HRP2 can disrupt the integrity of an endothelial barrier (Pal et al., 2016). 
Addition of parasites that produce HRP2 (but not parasites that do not make HRP2) or 
recombinant HRP2 protein to the monolayer of endothelial cells results in redistribution of 
tight junction and adherens junction proteins, and disruption of the barrier formed by the cell 
monolayer. Blocking of key signalling factors in the host cell prevents the disruption caused 
by HRP2 supporting a model of inflammasome mediated activation of the innate immune 
system in this process. Exposure to HRP2 also increases the number of VCAM-1 and ICAM-
1 receptors on the surface of endothelical cells. Both receptors can be used by infected 
erythrocytes to adhere to endothelial cells suggesting that activation of an inflammatory 
response may enhance cytoadherence and sequestration of parasites (Pal et al., 2016). 
Although mouse malaria parasites lack an HRP2 homolog, injection of HRP2 protein reduces 
survival of infected mice (Pal et al., 2017). It remains to be determined whether the incidence 
of cerebral malaria in humans is lower in infections caused by HRP2-negative parasites. 
Maurer’s cleft associated histidine-rich protein 1 (MAHRP-1) is an exported protein localized 
to Maurer’s clefts. The protein contains a single transmembrane segment and a repetitive 
histidine-rich C-terminus, and is involved in protein trafficking within the infected 
erythrocyte (Spycher et al., 2008). Like HRP2, the repetitive histidine-rich sequence of 
MAHRP is implicated in heme detoxification (Papalexis et al., 2001). The repetitive 
sequence is able to bind ferric heme, which is toxic to cells, and accelerates its degradation 
mediated by hydrogen peroxide. This suggests that the histidine-rich sequence of MAHRP-1 
may play a role in scavenging ferric heme and detoxification of reactive oxygen species 
within the infected erythrocyte (Spycher et al., 2003). Notably, the binding stoichiometry 
between ferric heme and MAHRP-1 is proportional to the number of repeats within the 
protein. This suggests that the potential protective function of MAHRP-1 could be influenced 
by repeat expansion (Spycher et al., 2003). 
Histidine-rich repetitive proteins and diagnosis of malaria 
The World Health Organisation now recommends diagnostic testing of people with suspected 
malaria before treatment (WHO, 2016). Rapid diagnostic tests (RDTs) represent an effective 
tool in this context. Most RDTs utilize antibodies to detect the HRP2 protein in blood. The 
mature protein, after cleavage of the PEXEL/HT motif (Chang et al., 2008), comprises 
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histidine-rich repeated sequences which form the epitopes recognized in RDTs (Wellems and 
Howard, 1986). More than 20 sequence variants of these repeat sequences have been 
identified (Baker et al., 2010, Deme et al., 2014). There is significant polymorphism in 
overall length, sequence composition of the repeated motifs, and the number of repeated 
motifs, between different P. falciparum strains (Baker et al., 2010, Baker et al., 2005, Deme 
et al., 2014, Ramutton et al., 2012) but there is currently no indication that sequence 
polymorphism can cause false negative RDT tests (Baker et al., 2010, Ramutton et al., 2012). 
However, increasing RDT use may place a selective pressure on the HRP2 gene and a 
contraction or mutation of repeats recognised by antibodies in RDTs may result in reduced 
test sensitivity or failure. Parasites lacking the HRP2 gene, initially identified in Peru 
(Gamboa et al., 2010) and subsequently other regions, do yield negative HRP2 based RDT 
tests (Bharti et al., 2016, Amoah et al., 2016, Li et al., 2015, Murillo Solano et al., 2015, 
Akinyi Okoth et al., 2015, Abdallah et al., 2015, Kumar et al., 2013, Wurtz et al., 2013, 
Maltha et al., 2012, Houze et al., 2011, Koita et al., 2012, Dorado et al., 2016, Baldeviano et 
al., 2015, Cheng et al., 2014). 
 
CONCLUSION 
In summary, repetitive sequences are widespread in Plasmodium genomes (Mendes et al., 
2013) and are particularly abundant in P. falciparum genes. These dynamic sequences can 
arise, expand, or contract rapidly. Due to the assumption that they represent non-functional 
‘junk DNA’ and are challenging to accurately assemble from short-read sequence data, they 
are mostly excluded from genomic analyses. Indeed, it is reasonable to assume in many cases 
that repeats simply expand and contract rapidly due to frequent errors in DNA replication, 
and evolve neutrally. Although it is difficult to provide a universal explanation for the 
presence of these sequences in the parasite genome, it appears that relatively simple 
homopolymeric repeats tend to evolve neutrally but more complex sequences appear to be 
under selection suggesting that they are functional (Battistuzzi et al., 2016, Zilversmit et al., 
2010).  
The fraction of Plasmodium repetitive protein sequences that are functionally important 
remains unclear and most remain uncharacterized. It is evident that some sequences within 
open reading frames encode repetitive polypeptide sequences that can modulate protein 
activity or are integral to protein function forming key structural elements, binding sites for 
other proteins and ligands, and localisation signals. Repeat expansion and contraction can 
likely modulate and diversify protein function resulting in gain or loss of function phenotypes 
that allow the parasite to adapt under selective pressure. Despite the diverse functions of 
repetitive sequences it is conceptually clear in many cases how changes in repeat length 
might influence protein function and parasite phenotype. The development of new genetic 
tools will now allow the importance of these sequences to be tested. In the simplest cases, 
relatively small changes in length of diverse repeat types may alter protein folding efficiency, 
stability, or aggregation leading to selective advantage for a parasite. In cases such as the 
CTD of RNA Polymerase II, where repeat sequences have very specific functions in the 
regulated recruitment of protein binding partners, changes in repeat number may fine tune 
protein function in a manner proportional to the number of repeats. The abundance of 
repetitive sequences that are recognized by the immune system and the occurrence of 
functional repetitive sequences in proteins such as KAHRP and REX1 that are central players 
in the pathology of severe malaria, highlight why an understanding of these sequences is 
important to our understanding of severe disease, its treatment, and prevention.  
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Figure legends: 
Figure 1. Repeat expansion and contraction during DNA replication and unequal 
crossing over in meiosis. 
Figure 2. The Plasmodium falciparum life cycle. A) Sporozoites are injected from the 
salivary glands of the Anopheles mosquito and migrate to the host liver. B) Upon invasion of 
hepatocytes, thousands of merozoites are produced and subsequently released into the 
bloodstream. C) Merozoites invade host erythrocytes and cycle through the ring, trophozoite 
and schizont stages before daughter merozoites egress from the host erythrocyte and invade 
new cells. D) A small proportion of parasites differentiate into male and female gametocytes. 
E) Gametocytes are ingested into the mosquito’s midgut as it takes a blood meal where they 
form gametes and fuse to form a diploid zygote. The zygote differentiates into an ookinete 
which develops into an oocyst within the midgut wall. Upon oocyst rupture, sporozoites are 
released into the hemolymph and travel to the mosquito salivary gland. Proteins containing 
repetitive/low complexity sequences are labelled at the approximate life stage where they are 
utilised. 
Figure 3. RNA Polymerase II C-terminal domain – phosphorylation and recruitment of 
proteins by the RNA pol II CTD during transcription 
 
Figure 4. Repetitive proteins exported into the host cell. Many proteins are exported into 
the host erythrocyte by P. falciparum. These are involved in creating new structures within 
the host cell: membranous structures called Maurer’s clefts (MC) appear in the host cell 
cytoplasm, a tubovesicular network’ (TVN) extends from the parasitophorous vacuole (PV), 
and ‘knob’ protrusions form on the cell surface which present the cytoadhesive surface 
protein PfEMP1. Many repetitive proteins interact with the spectrin cytoskeleton of the 
erythrocyte resulting in increased cell rigidity. 
Figure 5. Expansion and contraction of lysine-rich repetitive sequences and changes in 
protein localization or protein binding affinity 
The top panel illustrates the correlation between the length of a lysine-rich sequence from the 
protein GARP and the efficiency with which it is targeted to the erythrocyte periphery. 
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The lower panel illustrates the changes in binding affinity between β-spectrin and KAHRP 
repeats as the number of repeats in KAHRP is altered.  	
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 Gene	Identifier	 Alias	 Consensus	Motif	in	3D7	 Number	of	Repeats	 Localisation		PF3D7_0930300	 MSP1	 GASAQS	(GSGGSVASG/	SGGSVT)*	 2-6	(3-5/	4)	 Merozoite	surface	PF3D7_0206800	 MSP2	 AGGS	(TTTESNSPSPPI	PAGAGASGNP/AGAGASGS/	GASGSG/SGSAGG/	GAGAS/SGSAG)	*	
7-11	(4	6/8	13/6	9/3)	
Merozoite	surface	
PF3D7_0207600	 SERA5	 QGSTGASP		 3-12		 PV	+	Merozoite	surface	PF3D7_1035300	 GLURP	 EILPEDKNEKVQHEIVEVE	SEKSVSEPAEHVEIV	 4-14	3	 Merozoite	surface	PF3D7_1036400	 LSA1	 DLEQERLAKEKLQEQQS	 32-93	 Liver	Stage	PF3D7_0318200	 RNA	polymerase	2	 YSPTSPK	 6-11	 Nucleus	PF3D7_0831800	 HRP2	 AHHAAD	 38-46	 RBC	cytoplasm	PF3D7_1222600	 AP2-G	**	 KNN	 7-9	 Nucleus		 	 DTYN	 16-18	PF3D7_1370300	 MAHRP1	 HDHD	 3-5	 Maurer’s	Clefts		 	 DHG	 6-12	PF3D7_0304600	 CSP	 NANP	 40-46	 Sporozoite	Surface	PF3D7_0935900	 REX1	 KPQAEKDASKLTTTYDQTKEV	 3-6	 Maurer’s	Clefts		 	 NKETKPQNDKYTL	 2	PF3D7_0501300	 SBP1	 ASGIGNLVGDA	 5-6	 Maurer’s	Clefts		 	 QNAQ	 7-14	PF3D7_1149000	 Pf332	 PVEEKNVSEEI	 6-11	 Maurer’s	Clefts		 	 FVTGELPEEDIINEKVQEEEE	 3-5		 	 EESASEEIVEDEGSV	 5-7	
30		
	 	 ENVEEKKTMDEEIVDQGSVV	 3-4		 	 TEEVVEEEGSV	 5-10		 	 EEVVEEGSAT	 2-11		 	 EEIVEEEESSS	 11-12		 	 EEIVEEEGSVV	 10-24		 	 SVTEELVDEG	 2-3		 	 TEEIVED-EGSF	 6-7		 	 NEEILEEEGSY	 6-11		 	 GSATDYFVGQGSDNEEIIEE	 2-4		 	 IKEEQLDSEE	 6-20		 	 EVEEVSVDD	 2-5		 	 EEIEEIESVT	 2-4		 	 TEDVEEVSS	 4-8	PF3D7_0401800	 PFD80	 STA	 9-18	 Maurer’s	Clefts		 	 RSASAASTT	 8-12		 	 STSTTQSPST	 3-6	PF3D7_0102200	 RESA	 EEPTVADEHV	 6-8	 RBC	periphery		 	 EENV	 41-47	PF3D7_0113000	 GARP	 EKK	 12-17	 RBC	periphery		 	 EKEKKKQ	 7		 	 EEHKE	 8-9		 	 KGKKD	 5		 	 EEDEDDA	 8-10	PF3D7_0201900	 PfEMP3	 LEEYNETDLAKGKEVTNKAHEN	 17-19	 RBC	periphery		 	 KNKELQNKGSEGLKENAEL	 9-12		 	 NKDISNKDMKNKELL	 2-3		 	 QQNTGLKNTPSEG	 54-87	PF3D7_0202000	 KAHRP	 SKKHKDHDGEKKK	 4	 RBC	periphery		 	 ATKEASTSKE	 4-7	PF3D7_0402000	 PHISTa	 KQGGKKEEV	 9-14	 RBC	periphery	
31		
PF3D7_0500800	 MESA	 GESKET	 11-22	 RBC	periphery		 	 EKNDEKKDKVLGEGDKEDVK	 4		 	 KEKEEV	 7-11		 	 KEKEEV	 3-9		 	 ESEE	 17-26	PF3D7_0532400	 LYMP	 NKKVRGA	 5	 RBC	periphery		 	 ENKKAGT	 5-7	PF3D7_1102300	 N/A	 ERKEREEREKK	 9	 RBC	periphery		 	 EREKREKKEKE	 13-14	PF3D7_1148700	 GEXP12	 KECVPNECMK	 8	 RBC	periphery	PF3D7_1201000	 PHISTb/c	 EKDEK	 18-36	 RBC	periphery		 	 DDDDEDDED	 7-8	PF3D7_1476200	 PHISTb	 KEQEKEKERKRKE	 4	 RBC	periphery	PF3D7_1301400	 HYP12	 KKKEKQE	 8	 RBC	cytoplasm		 	 NEDE	 12		
Table 1. Repetitive sequences in Plasmodium falciparum proteins 
The repeat consensus for each protein was determined from P. falciparum 3D7 strain 
sequences using the programme XSTREAM, with gaps removed for clarity. The phases of 
some repeats were adjusted to those described in the literature. (*) Where the repeating motif 
differs between isolates the alternative repeating motifs are represented after the 3D7 
consensus sequence. Variation in repeat numbers seen in 16 different P. falciparum strains 
(3D7, IT, HB3, DD2, 7G8, CD1, GA1, GB4, GN1, KE1, KH1, KH2, ML1, SD1, SN1, TG1, 
where two-letter codes represent the country of origin for the 11 field isolates) were 
determined manually using Jalview with TCOFFEE used to align the sequences. (**) AP2-G 
also contains several poly-N sequences which vary by up to 12 residues. Long-read PACBIO 
genome sequencing data was obtained from the Pf3K consortium. 	
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